NRC Health Line of Credit, Current
NRC Health (NRC) had Line of Credit, Current of $3.50 million as of 2025-03-31, per its 10-Q filed 2025-05-09.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt and Lease Obligation, Current › Long-Term Debt, Current Maturities
us-gaap:LinesOfCreditCurrent · last filed 2025-05-09
- 2025-03-31: Line of Credit, Current $3.50M.
- 2024-12-31: Line of Credit, Current $0.00.
- 2024-09-30: Line of Credit, Current $5.00M.
- 2024-06-30: Line of Credit, Current $9.00M.
| Period end | Line of Credit, Current |
|---|---|
| 2025-03-31 | $3.50M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $0.00 10-Q · filed 2025-05-09 |
| 2024-09-30 | $5.00M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $9.00M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $7.00M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $0.00 10-Q · filed 2024-11-08 |
| 2023-09-30 | $5.00M 10-Q · filed 2023-11-09 |
| 2022-12-31 | $0.00 10-Q · filed 2023-11-09 |
| 2019-06-30 | $1.00M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $1.75M 10-Q · filed 2019-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |